At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Photon +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Proton Therapy for Peripheral Lymph Nodes in Breast Cancer
In Brief
A clinical study evaluating Photon and 3D-Proton/Conventional plan or 3D-proton only for Breast Cancer. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if proton radiation therapy will reduce the amount of heart that is exposed to radiation, thereby decreasing the frequency and/or severity of any cardiac side effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2011
Enrollment StartApr 2012
Primary CompletionMar 2014
Study CompletionMay 2018
TodayJul 2026
First PostedJun 3, 2011
Enrollment StartApr 1, 2012
Primary CompletionMar 1, 2014
Study CompletionMay 23, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 15.1 years ago
Interventions
Photonradiation
50.4 Gy to the breast/chest wall and peripheral lymph nodes at 1.8 Gy per fraction
3D-Proton/Conventional plan or 3D-proton onlyradiation
50.4 Cobalt Gray Equivalent/Gray to the breast/chest wall and peripheral lymph nodes at 1.8 Cobalt Gray Equivalent/Gray per fraction